Incidence and Timing of Epstein–Barr Virus Whole Blood DNAemia in Epstein–Barr Virus‐Mismatched Adult and Pediatric Solid Organ Transplant Recipients
Monitoring for DA-EBV should be focused on months 2-6 post-transplant. Less frequent whole blood EBV VL monitoring is likely a safe option in recipients less than 6 months old and recipients 6-12 months old with donors less than 12 months old.
Authors
- Curtis Mabilangan (ORCID: https://orcid.org/0000-0002-9581-3682)
- Jutta K. Preiksaitis (ORCID: https://orcid.org/0000-0002-0481-9692)
- Catherine Burton (ORCID: https://orcid.org/0000-0002-8361-5582)
Institutions
- University of Alberta (CA)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1111/tid.70042
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alberta Health Services